ArticleInternational journal of applied & basic medical research
Cardiometabolic Risk Clustering and Surrogate Markers of Insulin Resistance in Adolescents.
Article in International journal of applied & basic medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adolescent obesity is increasingly linked to early insulin resistance (IR) and clustering of cardiometabolic abnormalities, including impaired glucose regulation, dyslipidemia, inflammation, and liver dysfunction. Identifying at-risk adolescents remains challenging due to physiological variability and a lack of standardized definitions. Aim: The aim of this study was to identify simple and reliable surrogate markers of IR and associated cardiometabolic risk in overweight and obese adolescents. Materials and Methods: In this cross-sectional study, 182 adolescents aged 10-19 years underwent detailed anthropometric, clinical, and biochemical evaluation, including fasting glucose, insulin, lipid profile, alanine aminotransferase (ALT), uric acid, and high-sensitivity C-reactive protein (hs-CRP). IR was defined as homeostatic model assessment of IR (HOMA-IR) ≥2.5, and associations with demographic, anthropometric, lifestyle, dietary, clinical, and metabolic factors were analyzed. Results: IR was identified in 62.6% of participants and was more common among obese and pubertal adolescents. Central obesity was present not only in the overweight and obese groups but also in 11.2% of normal-weight adolescents, indicating metabolic risk beyond body mass index (BMI). Measures of central adiposity, particularly waist-to-height ratio (WHtR), showed stronger associations with IR than BMI. IR-positive adolescents demonstrated clustering of metabolic, inflammatory, and hepatic abnormalities, including elevated glucose, insulin, triglycerides, triglyceride: high-density lipoprotein cholesterol (TG: HDL-C) ratio, hs-CRP, uric acid, and ALT, with reduced HDL-C. Acanthosis nigricans, low physical activity, poor sleep, and increased screen time were also more frequent. Metabolic syndrome was present in 13.18% of participants. Conclusion: IR and cardiometabolic risk are highly prevalent in adolescents with obesity. WHtR, TG: HDL-C ratio, ALT, hs-CRP, and acanthosis nigricans may serve as practical surrogate markers for identifying adolescents with HOMA-IR-defined IR and supporting early preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.